Ciprofloxacin In Dextrose Injection, Solution
Product Images NDC 0409-2300

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin In Dextrose (NDC 0409-2300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cip0h 0006 01)

Chemical structure of ciprofloxacin, the active ingredient in Ciprofloxacin in Dextrose intravenous injection. The diagram shows the molecular framework including its characteristic fluorine atom and bicyclic system.*

FDA Label Image

Principal Display Panel – 100 mL Carton Label (Cip0h 0006 02)

Packaging label for Ciprofloxacin 200 mg/100 mL injection solution in 5% Dextrose, USP. The label shows a carton designed to hold 24 bags of 100 mL each. Labeler Hospira, Inc. is identified along with NDC 0409-2300-24. The label includes storage instructions, a barcode, and recycling information on the carton layout.*

FDA Label Image

Principal Display Panel – 100 mL Pouch Label (Cip0h 0006 03)

Label for Ciprofloxacin Injection, Solution 200 mg/100 mL (2 mg/mL) in 5% Dextrose Injection, USP. Single-dose flexible plastic container, sterile and preservative-free. Distributed by Hospira, Inc. Contains bar code and storage, usage, and handling instructions. Made in India.*

FDA Label Image

Principal Display Panel – 100 mL Bag Label (Cip0h 0006 04)

Label for Ciprofloxacin 200 mg/100 mL (2 mg/mL) injection, solution in 5% Dextrose for intravenous use. The label includes administration instructions, ingredients, cautions, and is distributed by Hospira, Inc. It features a barcode and indicates the product is preservative-free and supplied in a single-dose flexible plastic container.*

FDA Label Image

Principal Display Panel – 200 mL Carton Label (Cip0h 0006 05)

Packaging label for Ciprofloxacin 400 mg/200 mL (2 mg/mL) in 5% Dextrose Injection, USP, an intravenous injection, solution. The label indicates a package size of 24 x 200 mL bags and lists Hospira, Inc. as the labeler. The label prominently displays the product name, strength, and formulation details in orange. Storage instructions and a barcode are visible on the label.*

FDA Label Image

Principal Display Panel – 200 mL Pouch Label (Cip0h 0006 06)

Label for Ciprofloxacin 400 mg/200 mL (2 mg/mL) in 5% Dextrose Injection, USP, an intravenous injection solution. The label bears instructions for use, storage conditions, and cautions, specifies it is a single-dose flexible plastic container, and states the product is distributed by Hospira, Inc., made in India. The NDC code 0409-3300-01 and package size of 200 mL are visible.*

FDA Label Image

Principal Display Panel – 200 mL Bag Label (Cip0h 0006 07)

Label for Ciprofloxacin 400 mg/200 mL injection solution in 5% Dextrose, USP. The label indicates intravenous administration and specifies infusion over 60 minutes. It states the product is sterile, nonpyrogenic, preservative-free, and distributed by Hospira, Inc. Ingredients and usage cautions are included. Product is for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.